Middle East Healthcare Company (“MEAHCO” or the “Company”) announces that the Capital Market Authority (“CMA”) has approved its request to postpone the initial public offering (“IPO”) of 27,612,000 shares representing 30% of the Company’s share capital in view of prevailing market conditions. The CMA had approved the IPO of MEAHCO on 19/03/1437H (Corresponding to 30/12/2015G). New dates for institutional book building and retail offer period will be announced in due course. The new CMA approval regarding the postponement dated 08/04/1437H (Corresponding to 18/01/2016G) states that the offer must be concluded no later than 22/06/1437H (Corresponding to 31/03/2016G), otherwise the CMA’s approval of the Company's prospectus and the IPO will be considered canceled.